Podcasts about Breast cancer

How many times have you said, or heard yourself think, I did all the things? We follow the protocols, take the supplements, change the food, and quietly believe that if we just do it well enough, we will be safe. So what happens when the body does something we did not sign up for anyway? In this episode, I sit with three truths that sound heavy at first and actually set a lot of us free. The goal is not to convince yourself that nothing bad will happen. It is to become the woman who knows she can live fully without knowing what comes next.   Resources Mentioned: Download for iPhone:  https://apps.apple.com/us/app/kajabi/id1485646310 Download for Android:  https://play.google.com/store/apps/details?id=kajabi.kajabiapp&hl=en_US Work with Laura: https://www.thebreastcancerrecoverycoach.com/health    Let's Connect! If this episode helped you breathe a little easier, please share it with a friend or leave a review. Every share helps spread this message of hope, healing, and whole-person wellness.

Dame Meera Syal is a multi-award winning writer and actor, and a name and face very familiar to many of us having graced our screens for decades now. She's just published her first memoir and is also currently on stage in The Children at the Lyric Hammersmith Theatre in London. With her trademark warmth and humour she joins Anita Rani in the studio.A breakthrough breast cancer drug, Enhertu, has been approved for NHS use in England. Charities and patients have campaigned for it to be more widely available since 2024, when the National Institute for Health and Care Excellence (NICE) said Enhertu was not good value for money. The drug can give patients almost seven extra months to live on average - with some living up to three years longer. Women in Scotland have had access to the drug on the NHS since 2023, and it is available in 26 other European countries. Anita is joined by campaigner Sophie Blake who has stage 4 breast cancer and Dr Simon Vincent, Chief Scientific Officer at Breast Cancer Now.In our recent series of features about Daddy Issues, reporter Jo Morris has been speaking to listeners exploring the impact of paternal absence. Here, Anita is joined by Emma and her father Arthur, who share their story. Emma bonded with her father over sport, as she was a competitive swimmer, and Arthur was a British four time World Powerlifting Champion. But then Arthur became addicted to drugs and left the family home. They discuss the impact of paternal absence and describe how through their Christian faith they came to forgiveness and reconciliation. Founded two years ago by four Black SEND mothers, the Black Child Down Syndrome Project was created to address the lack of representation and support for Black families raising children with Down Syndrome. Earlier this year, their Reflecting Radiance exhibition in London showcased portraits of children supported by the project. Photographed by photographer and Oscar-nominated filmmaker Misan Harriman, the exhibition featured a takeover of the Piccadilly Lights. The organisation has since been nominated for a BBC Make a Difference Award and a National Diversity Award. Co-founders Danise Bartlett-Grant and Oneness Sankara join Anita.And Bonnie Greer, the playwright, novelist and cultural commentator, who died this week, is remembered. Presenter: Anita Rani Producer: Corinna Jones

In the first hour of the Chase & Big Joe Show, the guys shared their question of the day asking for cow milking advice for the Nashville Fair this evening. Later in the hour, B.R.A. Groups representatives joined the sho to talk kore about Breast Cancer and help raise money for their organization. Listen to hear more.

In the first hour of the Chase & Big Joe Show, the guys shared their question of the day asking for cow milking advice for the Nashville Fair this evening. Later in the hour, B.R.A. Groups representatives joined the sho to talk kore about Breast Cancer and help raise money for their organization. Listen to hear more. In the second hour, Kevin Tod with The Sports Brokers joined the show and shared his thoughts on his play of the day and play of the weekend. Later in the hour, Chase reacted to Todd's picks and shared some of his games he is looking forward to watching. To wrap up the hour, the guys shared their crazy spring break stories. In the final hour, Chase & Big Joe discussed the oldest NFL stadiums and why neutral sight games are the worst. Later in the hour, Big Joe previewed the MTSU v Nevada game. To wrap up the show as always, the guys played Celebrity Birthdays.

Send us Fan MailTodays Episode  Contain a "Hodgepodge of Health Secrets" Today we look at numerous habits that may be causing you health issues. 1. Why Fertility Rates or down. The one thing Men are wearing that takes sperm to Zero!!!2. Bad Habits that are causing breast cancer you can change now3. Does your water bottle contain more bacteria than your toilet seat?4. Protein that may be causing kidney damage. 5. Can a walk in the forest boost immunity? What's happening here? phytoncides6. Your Farts can tell you a lot about your microbiome.7. Botox ToxicitySee the website for the next dates of our 10 Day Healing Retreat. Support the showVisit our websiteFollow us!YouTube Instagram Facebook Give us a call at (208) 378-9911David's favorite Supplements and Natural Body Products Get your favorite supplements 15% discount & purity testedSuper PatchStem Cell Activation PatchesCreate your EMF Safe SpacesDisclaimerNothing here is meant to diagnose, cure, or treat any disease. Seek out a qualified healthcare professional to see if anything mentioned in this podcast is right for you.

Brought to you by the English Programme. Featuring news, politics, popular culture, celebrity trivia, quizzes, book readings, and a whole host of fun.Support Our Rescue Cats | Our Blog | Get New Episodes By Email | Rumble | X | YouTube | NewsK365 on Spreaker | Get New Blog Posts By Email | Throne Wishlist |

Brought to you by the English Programme. Featuring news, politics, popular culture, celebrity trivia, quizzes, book readings, and a whole host of fun.Support Our Rescue Cats | Our Blog | Get New Episodes By Email | Rumble | X | YouTube | NewsK365 on Spreaker | Get New Blog Posts By Email | Throne Wishlist |

Sarah introduces an Evolving Wellness episode on estrogen clearance, perimenopause/menopause, and why estrogen therapy isn't one-size-fits-all, then interviews John and David from Mera Labs, whose work on sulforaphane began after both of their wives faced breast cancer. They explain how sulforaphane activates NRF2, supporting phase 2/3 detoxification, antioxidant responses, mitochondrial function, and mitophagy, and discuss circadian oscillations of NRF2. Sarah shares her experience of heavy bleeding, PMS, and low ferritin improving after several cycles on their product, with benefits also noted for her autistic teen. The guests differentiate stabilized sulforaphane from glucoraphanin products, describe synergy from added PEITC, discuss dosing timing, toxins/microplastics and endocrine disruptors, DIM questions, stress and vagal regulation, and note a rare microbiome-driven estrogen recycling condition linked to galactorrhea— Connect with John and Davidhttps://mara-labs.com/ https://www.instagram.com/themaralabs/ For the next week, Evolving Wellness loyal listeners can get an exclusive 25% off all Mara Labs products when you go to www.mara-labs.com/SARAHK and use code SARAHK at checkout. After one week, the code will return to the standard 15% off._________Timestamp:00:00 Microbiome Estrogen Recycling00:44 Why This Episode Matters03:14 Podcast Intro and Disclaimers04:27 Meet the Mera Labs Founders10:26 Sarah's Estrogen Clearance Story14:57 Sulforaphane Science and Nrf231:30 DIM vs Sulforaphane Debate35:09 Minimize Menopause Formula37:54 Estrogen Therapy Prep41:58 Stress Epigenetics Reset44:38 Vagus Nerve Tools49:42 Sulforaphane Dosing Guide52:44 Toxins Microplastics Foods01:05:29 NRF2 Safety Wrap Up——— This video is not medical advice & as a supporter to you and your health journey - I encourage you to monitor your labs and work with a professional!________________________________________Get all my free guides and product recommendations to get started on your journey!https://www.sarahkleinerwellness.com/all-free-resourcesCheck out all my courses to understand how to improve your mitochondrial health & experience long lasting health! (Use code PODCAST to save 10%) -  https://www.sarahkleinerwellness.com/coursesMy free product guide with all product recommendations and discount codes:https://www.canva.com/design/DAF7mlgZpJI/xVyE4tiQFEWJmh_Xwx8Kbw/view?utm_content=DAF7mlgZpJIFree Webinar on Light & Health (includes free light bulb guide) - https://www.sarahkleinerwellness.com/mycircadianapp-free-webinarGet Early Access to Podcast Episodes & my Seasonal Food Course + UVB+Red Light Therapy course for free -  https://open.substack.com/pub/sarahkleinerwellness/p/uvbred-light-protocol?r=5eztl9&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true

We love a comeback story. The recovery after the diagnosis. The victory after the struggle. The inspiring lesson wrapped up with a pretty bow and, preferably, some flattering lighting. But what about when you're still in it? Allison Sweet Grant was barely 40, a mother of three, and just beginning her literary career when she was diagnosed with breast cancer. Her memoir, Lump: A Memoir in Ineloquent Reflections, tells the truth about breast cancer treatment and recovery without cleaning it up for public consumption. There's fear and hope. Gratitude and anger. Humor and grief.  In this episode, Allison and Nicole talk about the messy emotional reality of a breast cancer diagnosis, chemotherapy and cancer recovery, including the pressure to stay positive, the complicated role of caregivers, and why gratitude doesn't cancel out grief. We explore: Why gratitude, grief, fear, anger, humor, and hope can all exist at once The pressure cancer patients can feel to stay positive or find the “silver lining” How cancer affects spouses, children, caregivers, and the entire family Why humor and sarcasm can be powerful coping mechanisms during difficult experiences How the need to be liked or seen as a “good patient” can keep women from asking important questions Why bringing an advocate to medical appointments can make a difference How fear influences major healthcare decisions — and why Allison wishes she had paused more The ongoing fear of cancer recurrence and what it means to live in the complicated space between patient and survivor Because the truth doesn't need to be positive, polished, perfect, or profound to be worth telling. Thank you to our sponsors! Protect your loved ones without spying on them. Go to HeyPolo.com/work or use code WORK and get 70% off your first year Connect with Allison: Website: https://www.allisonsweetgrant.com/  Book: https://www.amazon.com/Lump-Reflections-Allison-Sweet-Grant-ebook/dp/B0GL1H4FJL/  Related Podcast Episodes: Survival Is Woman's Work with Kathy Giusti | 391 Joan Lunden on Reinvention, Leadership & Life Beyond the Script | 392 161 / Survivorship and Breast Cancer with Virginia Carnesale Share the Love: If you found this episode insightful, please share it with a friend, tag us on social media, and leave a review on your favorite podcast platform!

Welcome to another episode of the Oncology Brothers! In this episode, we dived into the recent FDA approval of camizestrant for the treatment of hormone receptor–positive metastatic breast cancer, based on the SERENA-6 trial. We welcomed Dr. Erica Mayer, a breast medical oncologist from the Dana-Farber Cancer Institute, who shared her insights on the trial's design, findings, and the significance of detecting ESR1 mutations before clinical progression. We discussed the implications of this approval, including the shift in treatment strategies, the importance of ctDNA monitoring, and the potential benefits for patient quality of life. Key topics covered in this episode: Overview of the SERENA-6 trial and its findings The role of ESR1 mutations in treatment resistance The efficacy and safety profile of camizestrant Practical insights on integrating next-generation sequencing (NGS) testing into clinical practice Management of side effects, including bradycardia and QT prolongation Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode is packed with valuable information.   Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o    Follow us on social media: ⁠X/Twitter: https://x.com/oncbrothers  ⁠Instagram: https://www.instagram.com/oncbrothers  Website: https://oncbrothers.com/    Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers! #Camizestrant, #SERENA6, #ESR1mutation, #BreastCancer, #OncologyBrothers  

A successful breast surgeon went looking for proof that soy was dangerous for breast cancer patients. She ended up finding something that shocked her! In this episode, Jarrod Roussel, PA-C and Anita Roussel, BSN, INHC, are sharing her findings, along with the simple health optimizing strategies that work with real life.Jarrod takes you to the estrogen receptor itself, where the real answer on soy, breast cancer risk, and recurrence is found, and revealing how tofu actually affects the men in your life as well.Then Anita gets into the second reason tofu stays out of most kitchens. It tasted terrible the times you tried it, and the reason has nothing to do with the tofu itself. She shares the health optimizing dish she gets requested to bring on repeat, the one people eat straight out of the bowl with a spoon and still cannot figure out how it tastes "So good!"Press play and find out what tofu is really doing for your body and discover how to have your body backing your God-given dreams 100%.Grab our cookbooks for the delicious time-saving recipes that will simplify your life, optimize your health, and save you countless hours every week. Shift your body from being your biggest hindrance to your #1 asset, inside Accelerator. This is the 8 week experience built for the high-performing, faith-driven entrepreneur ready to trade the world's way of "managing" health for the body optimization system that's backed by the Bible and the reliable research. This is not for everybody, but it is perfect for some of you. Seats are limited! Apply for the next cohort here.Want our favorite dried fruits and frozen berries shipped directly to your door? Find them here.

Featuring perspectives from Dr Aditya Bardia, Dr Kevin Kalinsky and Dr Joyce O'Shaughnessy, including the following topics: Introduction (0:00) Hormone Receptor-Positive Breast Cancer — Dr Kalinsky (1:18) HER2-Positive Breast Cancer — Dr Bardia (42:46) Triple-Negative Breast Cancer — Dr O'Shaughnessy (1:01:41) CME information and select publications

Alan interviews Lisa Crites. When Lisa Crites got breast cancer - she knew her life would be forever changed. Her doctor told her - to shower after surgery - she must wear a trash bag to keep her surgical drains clean. Lisa invented a much better solution: a waterproof Shower Shirt - used by breast cancer patients worldwide. Make sure to subscribe to the podcast at Apple Podcast, or wherever you get your podcasts, so you won't miss a single episode. Website: www.ShowerShirtInventor.com

Technology is rapidly changing the world around us – and the same is true in women's health. Artificial Intelligence holds enormous promise in understanding risk, detecting cancers earlier and improving treatment options and outcomes for breast cancer patients – but how do we get there and what should we be aware of along the way? Today we're welcoming Jillian Wright, the CEO of Onsite Women's Health, the leading provider of convenient, in-office breast health imaging services across the U.S., and Jane Perlmutter, a survivor of multiple cancers and devoted member of Susan G. Komen Advocates in Science program, which brings the patient voice to scientific research and clinical decisions. Takeaways AI can improve breast cancer detection and diagnosis AI can make breast imaging more consistent and effective Patients need a voice in how AI is used in healthcare AI must be developed with diversity, privacy and equity in mind Personalized care could reshape the future of breast cancer screening Chapters 00:00 — The promise of AI in breast health 05:12 — Understanding breast cancer risk 10:29 — How AI is transforming breast imaging 19:28 — The concerns around AI in healthcare 24:40 — The future of AI and cancer care Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

Vision language models (VLMs) are receiving growing attention in radiology. Kathy Dai, MD, is joined by Dorothy Sippo, MD, MPH, to discuss the article by He et al. exploring the use of VLMs for axillary lymph node assessment in patients with breast cancer. Full article: Vision Language Models for Ultrasound Assessment of Suspicious Axillary Lymph Nodes in Breast Cancer Follow AJR on Social Media LinkedIn: https://www.linkedin.com/showcase/ajr-radiology/ YouTube: https://www.youtube.com/channel/UCfFAYezkLMxJGMgIJLN0Dpg Instagram: https://www.instagram.com/ajr_radiology/ TikTok: https://www.tiktok.com/@ajr_radiology X: https://x.com/AJR_Radiology BlueSky: https://bsky.app/profile/ajrradiology.bsky.social

How can AI help predict breast cancer risk? Heta Ladumor, MD, discusses the AJR article by Xu et al. that developed a novel deep-learning tool for predicting risk from DBT examinations. Full article: Predicting 5-Year Breast Cancer Risk From Longitudinal Digital Breast Tomosynthesis: A Single-Center Retrospective Study Follow AJR on Social Media LinkedIn: https://www.linkedin.com/showcase/ajr-radiology/ YouTube: https://www.youtube.com/channel/UCfFAYezkLMxJGMgIJLN0Dpg Instagram: https://www.instagram.com/ajr_radiology/ TikTok: https://www.tiktok.com/@ajr_radiology X: https://x.com/AJR_Radiology BlueSky: https://bsky.app/profile/ajrradiology.bsky.social

Of all the things you thought would be complicated after finishing breast cancer treatment, deciding what to eat wasn't one of them. The indecision. The overwhelm. The worry. You couldn't have imagined the challenge in deciding what to have for dinner; but now you know. Digging through reams of nutrition information, trying to put it all together in a way that makes sense for your nutrition needs and wondering where to start is so confusing. But it doesn't have to be. In today's episode I share evidence-based strategies for taking that first step to eating with peace as a breast cancer survivor.After today's episode you'll understand: The five recommendations that have the biggest impact on your recurrence riskWhy nutrition information alone isn't enough to help you make impactful diet changes as a breast cancer survivorMy pro tips for creating sustainable nutrition habits that serve you in the long run___________________________________________________Click here for THE CLARITY SESSIONS packageClick here to get my brand new FREE guide; The 5 Foods Breast Cancer Survivors Worry About Most (and what the science really says)Follow me on Instagram @hormone.breastcancer.dietitian

Dr. Jenn Simmons talks with Dr. Robin Berzin about her path from an unexpected pre-med background to conventional medical training, then into functional medicine and entrepreneurship. The conversation covers the roots of Robin's interest in prevention, her early exposure to health and nutrition, and how she built Parsley Health into a national, insurance-covered practice.In this episode, they discuss why functional medicine can work alongside conventional care, how to think about root causes instead of symptom suppression alone, and what it takes to scale a health care company without losing clinical rigor. Robin also shares the realities of fundraising, leadership, and protecting her own health while building a company and raising three kids.Key topicsDr. Robin Berzin's origin story, from international relations and economics to medicineHow a college thesis on hormone-treated beef helped shape her interest in public health, nutrition, and cancer riskWhy she did not initially see herself as a science person, and how she later reframed medicine as pattern recognition and synthesisThe role of her father's internal medicine background, and why she still did not assume medicine was her pathHow yoga, meditation, organic food, and personal health experiences deepened her interest in prevention and whole-person careWhat functional medicine means in practice: using the same medical tools, but focusing on root causes, personalization, and preventionWhy Robin saw a need to standardize and scale functional medicine through Parsley HealthThe tension between conventional medicine and alternative medicine, and why she rejects all-or-nothing thinkingExamples of root-cause thinking, including recurrent UTIs, migraines, autoimmune disease, infertility, and chronic fatigueThe challenge of building trust with insurers through outcomes data, cost savings, and reduced utilizationWhat it took to raise capital as a female founder with no MBA and no prior business backgroundHow leadership changed as Parsley grew from a small team to a 120-person companyThe importance of listening to patients, not just investors or skeptics, when making company decisionsHow Robin maintains her own health with sleep, supplements, meditation, food choices, exercise, and self-monitoringHer hope that evidence-based functional medicine becomes part of standard primary careTimestamps00:00 - Why Dr. Robin Berzin stands out in functional medicine 01:22 - The unexpected path from undergrad to medicine 02:26 - A thesis on hormone-treated beef and public health 04:35 - Early exposure to cancer prevention and health research 06:12 - Having a doctor father, but not seeing medicine as an obvious path 07:01 - Why medicine is more about synthesis than equations 09:22 - Strengths that matter in clinical practice 10:56 - From conventional med school to a functional medicine career 12:40 - What functional medicine actually means 14:14 - Yoga, food, and becoming more aware of health 16:18 - Research, ADHD trials, and early clues about her own ADHD 18:12 - Early exposure to Mark Hyman and Dr. Oz 20:31 - Why Parsley Health was built to fix access and consistency problems 21:24 - Real outcomes from functional medicine care 22:33 - Why medicine should use both conventional and functional tools 23:47 - Root-cause care for UTIs and migraines 25:09 - Functional medicine versus paint-by-numbers primary care 26:04 - Making functional medicine accessible through a national platform 27:24 - The courage required to build a company while practicing medicine 28:29 - Trial, error, and the first steps as a founder 31:20 - Bootstrapping the first version of Parsley 33:28 - Building a patient base and hiring the first team 34:32 - Raising a first round as a female founder 36:11 - The fear and pressure of taking investor money 37:30 - Learning fundraising with help from other women in venture 38:26 - Why fundraising never really ends 39:23 - How investor relationships changed as Parsley grew 41:28 - Why medicine did not prepare her for executive leadership 42:16 - The hardest lessons in hiring and management 44:15 - When investor priorities pushed the company off course 46:17 - Choosing company survival while staying true to the mission 47:45 - Parsley's broader mission and why health care costs are unsustainable 49:34 - Why functional medicine should become standard primary care 50:01 - Using outcomes data to win over insurers 52:25 - Why people assumed Parsley was only for the “worried well” 53:29 - How the medical community has responded over time 54:20 - The rise of longevity medicine and ongoing skepticism 56:52 - Dark nights of the soul during fundraising and board conflict 59:51 - How Robin protects her own mental and physical health 62:52 - Sleep, data, and the reality of life as a busy founder 64:03 - Travel routines, intermittent fasting, and skincare 65:53 - What she hopes medicine will look like when her career is done 68:17 - Why impact is fastest when you stay in your lane 70:18 - Food dyes, public health priorities, and respecting different missions 73:16 - Curiosity, skepticism, and keeping the lamps lit 74:24 - What Parsley Health offers now and how to work with the teamConnect with Dr Robin Berzin & Parsley Health:Website: https://www.parsleyhealth.com/Instagram: https://www.instagram.com/robinberzinmd/To talk to a member of Dr. Jenn's team and learn more about working with Dr. Jenn visit: https://calendly.com/stephanie-1031/clarity-callTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideConnect with Dr. Jenn:Website:  https://www.perfeqtionimaging.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons

Five years cancer-free, Bridget thought she was in the clear — until a scan the day of a minor surgery revealed stage four metastatic breast cancer. A hospice and palliative care nurse practitioner herself, she talks with Cody about the oncologist who told her "we don't talk numbers, we talk living," the financial toll no one warns you about, her faith, and why she's determined to outlive every statistic she's ever been given. Join us for a conversation about living fully, on her own terms. Sponsored by Iliff Death Care Collective - https://www.iliff.edu/death-care-collective/

This week I'm joined by Dr. Eleonora Teplinsky, a medical oncologist specializing in breast and gynecologic cancers, for a conversation about what actually helps people live well with metastatic disease, not just longer. We talk about the shift toward quality of life conversations in oncology, why it took so long to get here, and what it really takes to build a care team that listens. Dr. Teplinsky also opens up about her new book, Beyond the Pink: Navigating Life, Health, and Breast Cancer, out at the end of September, and why she wanted to write something that goes beyond treatment into the parts of this experience we rarely get time to talk about in a clinic visit.We also get into the practical stuff. How to make the most of a short appointment, navigating the maze of specialists and ancillary care, the realities of insurance pushback on imaging, and what's actually changing in the metastatic treatment landscape right now. If you've ever left an oncology appointment with more questions than answers, this one is for you.Heather was diagnosed with metastatic breast cancer at 26 and has now been living with the disease for more than 25 years. Through this podcast she shares perspective, lived experience, and conversations that help people navigate life with metastatic cancer.Book ClubJoin the There's No Cancer In This Book Club:https://theresnocancerinthisbookclub.comSensational Survivor SeriesIf you have been living with metastatic breast cancer for 10 years or more and would like to share your story on the podcast, you can apply here:https://forms.gle/6H9K7NXMAeN1QEv87Digital Guideshttps://shop.heatherjose.com/all-guides/Listener QuestionsHave a question you'd like answered in a future episode? Submit it through the contact form:https://heatherjose.comConnect with HeatherInstagram: https://instagram.com/heatherbjoseWebsite: https://heatherjose.comMusicIntro and outro music for the podcast was created by Heather's son, Ty. You can find his music here:Instagram: https://instagram.com/tyjosee

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we unveil a series of transformative strides in drug approvals, clinical trials, and regulatory landscapes that are reshaping the future of patient care. AstraZeneca's camizestrant, now branded as Etcamah, has received FDA approval for treating ESR1-mutated hormone receptor-positive, HER2-negative advanced breast cancer. This approval is a testament to the potential of selective estrogen receptor degraders (SERDs) in oncology. The Phase 3 trial results highlight camizestrant's efficacy when combined with CDK4/6 inhibitors, offering a tailored therapeutic strategy for patients with ESR1 mutations. Such advancements in personalized oncology are steering the industry toward more precise treatment paradigms. Complementing this approval, Guardant Health's Guardant360 CDx has been sanctioned as a companion diagnostic tool for camizestrant. The liquid biopsy-based method precisely identifies ESR1 mutations, underscoring the growing reliance on precision diagnostics in cancer management. As precision medicine continues to evolve, integrating diagnostics with therapeutics becomes crucial in achieving optimal patient outcomes. Bristol Myers Squibb has made headlines with its CAR-T cell therapy, arlocabtagene autoleucel, showing efficacy in its Phase 3 trial for GPRC5D-targeted relapsed or refractory multiple myeloma. This advancement reflects the burgeoning application of cell-based treatments in hematological malignancies and signals a shift towards personalized immunotherapy strategies promising improved patient outcomes. On a related note, Brainchild Bio's significant $116 million fundraising initiative aims to advance CAR-T therapies tailored for childhood brain cancers. This development highlights the potential of CAR-T technology beyond hematologic cancers and indicates an intensified focus on pediatric oncology therapeutics. In regulatory news, Shionogi's cefiderocol has gained approval from Australia's Therapeutic Goods Administration (TGA) for combating carbapenem-resistant gram-negative bacterial infections. Cefiderocol addresses critical needs in combating multidrug-resistant pathogens, particularly in urinary tract infections, and highlights ongoing global efforts to tackle antimicrobial resistance. Clinical trials continue to yield promising outcomes. Pharvaris' deucrictibant showcased positive results in its Phase 3 trial for hereditary angioedema by effectively targeting the bradykinin B2 receptor. Novo Nordisk's semaglutide (Wegovy) demonstrated remarkable efficacy in reducing obesity among children during its Phase 3 trials. These results emphasize continued innovation in treating metabolic disorders and rare diseases by leveraging small molecule therapeutics and receptor modulators. Not all developments have been positive. Novartis and Ionis Pharmaceuticals faced setbacks with pelacarsen failing to meet endpoints in a Phase 3 trial aimed at reducing major cardiovascular events despite lowering lipoprotein(a). This underscores the challenges of translating promising biomarkers into effective therapeutic interventions. Regulatory challenges were also observed as American Regent recalled batches of epinephrine due to contamination issues, and Boston Scientific recalled spinal cord implants linked to serious injuries. These instances underscore the importance of stringent quality control and regulatory compliance to ensure patient safety. Meanwhile, Amgen's DLL3-targeted therapy, Imdelltra, achieved an overall survival win in a first-line setting for small cell lung cancer (SCLC), although specific numerical results were not disclosed. This bispecific antibody could set a new standard for early intervention in SCLC, emphasizing the potential of targeted therapies in improving survival rates for aggressive cancers. In other advancements, Roche continues to dominate neurology with top positions in corporate reputation rankings within this therapeutic area. This accolade reflects Roche's commitment to innovation and patient-centric approaches to managing neurological disorders. As these developments unfold across various domains of pharmaceutical innovation and regulation, they collectively signal a dynamic era for the industry marked by rapid scientific progress and evolving treatment strategies. The implications are profound, offering potential improvements in patient outcomes through more targeted therapies while highlighting challenges such as clinical trial failures that necessitate continued diligence in drug development strategies. As these trends unfold, they hold promise for significant advancements in treatment efficacy and safety across various therapeutic areas. Thank you for tuning into Pharma Daily. Stay informed about the latest industry developments as we continue to explore the dynamic landscape of pharmaceutical innovations together.Support the show

What happens when the woman who has spent years treating breast cancer suddenly finds herself sitting on the other side of the diagnosis?In this deeply personal episode of The She Believed She Could™ Podcast, Allison Walsh sits down with Dr. Catherine “Sue” Hwang, a board-certified radiation oncologist specializing in breast cancer, who knows the cancer journey from both sides—as a physician and as a patient.After more than 15 years of caring for women with breast cancer, Dr. Hwang never expected to become a breast cancer patient herself. A routine mammogram revealed calcifications, followed by the discovery of multiple masses and an abnormal lymph node. Suddenly, the physician who understood the treatments, side effects, complications, and statistics was forced to experience the fear and uncertainty of being the patient herself.Dr. Hwang shares what she learned about the patient experience, breast cancer treatment, motherhood, vulnerability, hyper-independence, and accepting support. She talks honestly about how her community rallied around her, from bringing meals to helping with her children, and how the experience completely changed the way she thinks about community and caring for others.But one of the most important lessons came after treatment.Dr. Hwang explains why the end of chemotherapy, surgery, or radiation doesn't necessarily mean the end of the cancer journey. For many women, survivorship can bring an unexpected emotional and physical transition—a period where treatment ends, medical appointments become less frequent, everyone assumes you're okay, and you're left wondering, “What now?”That realization inspired Dr. Hwang to advocate for better breast cancer survivorship care and to help patients understand that struggling after treatment is not a failure. It's part of the journey.She also shares practical advice about mammograms, breast exams, knowing your body, recognizing potential breast cancer symptoms, and becoming your own healthcare advocate. Her message is especially powerful for women who have ever been told they're “too young” to worry about breast cancer or who feel uncomfortable pushing for additional answers.Dr. Hwang's story ultimately comes back to one powerful idea: you don't have to know how you're going to get through the entire journey. Sometimes, you simply have to take the next step.And then the next one.And eventually, you may look back and realize just how much you were capable of all along.What You'll Learn in This EpisodeWhat it's really like when a breast cancer oncologist becomes a cancer patient herselfWhy the period after breast cancer treatment can sometimes be harder than treatment itselfHow to navigate the emotional and physical challenges of cancer survivorship and finding a new normalWhy accepting help and leaning on your community and support system can be a powerful form of strengthHow cancer can change your perspective on motherhood, identity, work, and what truly mattersThe importance of mammograms, knowing your body, and paying attention to changes or symptomsWhy women need to become their own healthcare advocates and seek answers when something doesn't feel rightHow to cope with the fear and uncertainty surrounding cancer recurrenceHow Dr. Hwang's experience as a patient changed the way she now cares for and communicates with breast cancer patientsWhy you don't have to know how you'll get through the entire journey—you can simply take the next step, one day at a timeIf you or someone you know needs support on their cancer journey, visit: http://adventhealthcancerinstitute.com This episode is sponsored by AdventHealth for Women. Learn more about their Women's Health Navigation Team and how they're making healthcare simpler for women and their families at AdventHealthForWomen.com.Join Us at Iconic ImpactReady to create your next incredible chapter?The She Believed She Could™ ICONIC IMPACT takes place November 5, 2026, in The Center for Health and Wellbeing | Winter Park, Florida, bringing together ambitious, accomplished women for meaningful conversations around leadership, visibility, business growth, wellbeing, purpose, and impact. The experience continues November 6 with the exclusive VIP Impact Lab at Hi Hello Labs.

The first 30 days after being diagnosed with breast cancer can feel devastating. You're processing a lot of information, dealing with emotions and often trying to figure out what to do next. Joining us on Real Pink's 400th episode today is Jennifer Omholt, a journalist and 24-year cancer survivor who was diagnosed with stage 3 breast cancer when her son was just 16 months old. In the wake of her diagnosis, she desperately searched for something to ease her fear and confusion, but found nothing that offered comfort or clarity. Over the next two decades, she set out to create the resource she wished she'd had, so that no one would need to face the shock of a cancer diagnosis alone. Jennifer is here today to share her story and what helped carry her though her breast cancer experience. Key takeaways: You don't have to solve cancer all at once; focus on the next best step. Finding the right medical team can make a profound difference in your care. Self-advocacy means asking questions, trusting your instincts, and seeking second opinions. Letting others help can ease the emotional and practical burden of cancer. The fear of a diagnosis can fade as you gain knowledge, confidence, and a sense of control. Chapters 00:01:23 — A stage three diagnosis with a 16-month-old son 00:03:25 — Finding ways to manage fear and uncertainty 00:07:57 — The first 30 days after a breast cancer diagnosis 00:09:59 — Building a medical team you can trust 00:15:07 — Why self-advocacy can change your treatment Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

If you have ever finished treatment, rung the bell, and thought "wait, why do I feel worse now than I did during chemo," this episode is for you. Dr. Eleonora Teplinsky is back on the show, and there is a very good reason. She is a board-certified medical oncologist specializing in breast and gynecologic cancers, Director of Breast and Gynecologic Medical Oncology at Valley Health System in New Jersey, host of the Interlude podcast, and her first book, Beyond the Pink: Navigating Life, Health, and Breast Cancer, comes out September 29. Her core message is one we talk about here constantly: survivorship does not start when treatment ends. It starts the day you are diagnosed. We go deep into the things most women are never prepared for. Why the "after" is often harder than active treatment. Why a DEXA scan is only half the bone health picture and muscle mass is the piece almost no one measures. What the emerging GLP-1 and breast cancer recurrence research actually shows, and what it does not show yet. Why vaginal estrogen is still being denied to women who have every guideline on their side. Where testosterone and systemic HRT fit in, and the three-bucket framework she uses to help patients decide. And how to tell trustworthy health information from the noise. Dr. Teplinsky wrote Beyond the Pink with more than 400 citations, and where the evidence does not exist yet, she says so. It is the resource she wished her patients had, and it is written to be brought into the exam room. In this episode Why survivorship begins on day one, not after your last treatment The gap in medical training around menopause, sexual health, and long-term survivorship Why the post-treatment period is often the hardest, and why the support disappears right when you need it Fear of recurrence and scanxiety, and what an oncologist actually says to patients living in it Bone health after an aromatase inhibitor: DEXA scans, calcium, vitamin D, and bone medications The muscle health conversation almost no one is having, sarcopenia, and how it is linked to aromatase inhibitor side effects and adherence How little movement it actually takes: resistance bands, dumbbells, and 20 minutes GLP-1s and breast cancer: the recurrence signal, what is still unknown, and why the source of your prescription matters Why "humans are not mice" and the caution around unstudied peptides Sexual health after cancer: body image, intimacy, dryness, bladder issues, and why sexual health is health Vaginal estrogen: the guidelines, the study that gets misquoted, and the link to reduced UTIs, sepsis, and hospitalizations Testosterone after breast cancer: the theoretical concerns, the hormone receptor nuance, and what newer data suggests Systemic HRT and the three-bucket framework: symptoms, recurrence risk, and your personal risk tolerance A chapter-by-chapter look inside Beyond the Pink Her three pieces of advice for someone newly diagnosed Being mindful of what you consume online, and why nothing good happens on social media after 10pm Connect with Dr. Eleonora Teplinsky Pre-order Beyond the Pink: Navigating Life, Health, and Breast Cancer (out September 29): https://interludecancerstories.com/book/ Pre-order on Amazon: https://www.amazon.com/Beyond-Pink-Navigating-Health-Breast/dp/1538777142 Instagram: https://www.instagram.com/drteplinsky/ Interlude podcast and website: https://interludecancerstories.com/ Connect with Jen Website: https://www.jendelvaux.com Instagram: https://www.instagram.com/jendelvaux Free guide, the changes I made after my diagnosis: https://www.jendelvaux.com/nowwhat If this episode spoke to you, share it with someone who needs it, and follow the show so you never miss an episode. Pre-order Beyond the Pink, take care of yourself, and be gentle with yourself. This episode is for educational purposes and is not medical advice. Please talk with your own care team about what is right for you.

Why is it that you can know exactly what would help you feel better, and still not do it? You already know to eat real food, to move your body, to rest. Knowledge was never the missing piece. So what is? In this episode, I share the moment I realized I needed a lifeline, and the thing I come back to again and again: lasting change is not built on willpower. It is built on quietly becoming the person who can hold the thing you say you want. You do not need another rule. You need to become the person the rule was never able to create.   Resources Mentioned: Take the free Sugar Challenge here:  https://www.thebreastcancerrecoverycoach.com/sugar Download for iPhone:  https://apps.apple.com/us/app/kajabi/id1485646310 Download for Android:  https://play.google.com/store/apps/details?id=kajabi.kajabiapp&hl=en_US Work with Laura: https://www.thebreastcancerrecoverycoach.com/health    Let's Connect! If this episode helped you breathe a little easier, please share it with a friend or leave a review. Every share helps spread this message of hope, healing, and whole-person wellness.

Dr. Jenn Simmons and Dr. Erica Schwartz on hormones, individualized care, and questioning mainstream medicineDr. Jenn Simmons sits down with Dr. Erica Schwartz for a candid conversation about women's health, hormone replacement, and the importance of individualized care. They discuss why hormone therapy is gaining renewed attention, why many providers are not adequately trained to prescribe it, and how patients can make more informed decisions about their health.They also explore breast screening, overdiagnosis, metabolic health, medical fear, and the value of having a trusted provider who looks at the whole person. Together, Dr. Jenn and Dr. Schwartz challenge one-size-fits-all medicine and make the case for thoughtful, relationship-based care.What You'll Learn:Why hormone therapy requires better provider education, not just wider accessHow outdated medical training continues to affect women's healthWhy individualized care is often more important than rigid protocols The difference between breast cancer prevention, diagnosis, and overdiagnosisWhy metabolic health is central to breast health and long-term wellnessHow watchful waiting can sometimes be safer than immediate testing or biopsyWhy progesterone and synthetic progestins should not be treated as the same thingWhat women should consider before using supplements, peptides, or extreme dietsWhy having a trusted healthcare provider can prevent conflicting and unnecessary treatmentsHow patients can question medical assumptions while taking greater responsibility for their health Timestamps00:00 - Why hormone conversations are surging and why training matters02:10 - Dr. Schwartz's path from conventional medicine to individualized care04:00 - Medical paternalism, discrimination, and resistance to change15:46 - Why mammography is diagnosis, not prevention17:32 - Hormone replacement, oral estrogen, and breast cancer concerns24:07 - Perimenopause labels, social media, and inadequate training30:30 - Why relationships matter more than protocols and lab results43:13 - Watchful waiting, breast biopsies, and the value of doing less45:55 - Metabolic health as a foundation for breast cancer prevention56:34 - Questioning mammography and taking responsibility for your care60:08 - Why modern medicine needs more time for patient relationshipsTo talk to a member of Dr. Jenn's team and learn more about working with Dr. Jenn visit: https://calendly.com/stephanie-1031/clarity-callTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideConnect with Dr. Jenn:Website:  https://www.perfeqtionimaging.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons

In this podcast episode, Hope S. Rugo, MD, FASCO, and Nerea Lopetegui-Lia, MD, discuss practice-informing data presented at ASCO 2026 for patients with early-stage hormone receptor (HR)–positive/HER2-negative breast cancer, including:Findings from the OPTIMA trial evaluating Prosigna gene expression testing to guide adjuvant chemotherapy decisions in patients with high-risk HR-positive/HER2-negative early breast cancerThe importance of ovarian function suppression plus endocrine therapy when considering chemotherapy-sparing strategies in premenopausal patientsResults from the NATALEE PAM50 biomarker analysis, showing ribociclib benefit across intrinsic subtypes with no significant treatment-by-subtype interactionPresenters:Hope S. Rugo, MD, FASCODirector, Women's Cancer ProgramDivision Chief, Breast Medical OncologyProfessor, Department of Medical Oncology & Therapeutics ResearchCity of Hope Comprehensive Cancer CenterProfessor Emeritus and Emeritus Winterhof Family Distinguished Professor of Breast OncologyUniversity of California, San FranciscoSan Francisco, CaliforniaNerea Lopetegui-Lia, MDAssistant ProfessorDivision of Medical Oncology, Breast SectionDepartment of Internal MedicineThe Ohio State UniversityColumbus, OhioGet access to all of our new podcasts by subscribing to the Decera Clinical Education [Oncology] Podcast on Apple Podcasts, YouTube Music, or Spotify.Link to full program: https://bit.ly/4x4u5AT Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  Episode resource links:  Zhou H et al.  Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355.  eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884  Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041   Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257  Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698.  Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930.  Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541.  Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.:  American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022.  Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485.  Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234.  Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455  Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666  Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301.  Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015  Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024  Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575  Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1  Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Does progesterone cause breast cancer—or could it actually play a protective role in the body? The answer isn't as simple as the headlines make it seem. In this episode, Dr. Brendan McCarthy breaks down one of the most confusing conversations in hormone health: the difference between bioidentical progesterone and synthetic progestins. Not all medications called “progesterone” are the same. They may protect the uterine lining in similar ways, but they can behave very differently throughout the body.  

How do you harness the power of visualization and unbreakable mental toughness to navigate extreme physical challenges and life-altering health battles? In this episode of The Slight Shift Show, Chris and Angela welcome a very special guest. Chris's wife and "hero," Kathy Berlow! From raising a large family to competing as a bodybuilder, completing an Ironman, running marathons, and climbing Mount Kilimanjaro, Kathy shares the mindset required to tackle extraordinary physical feats. The conversation takes a deeper, more emotional turn as Kathy opens up about surviving a grueling year-and-a-half struggle with nerve pain following surgery, and how she is applying her visualization techniques to her current fight against breast cancer. How to take on life's toughest battles! The Shift to "Go Big or Go Home": How supporting family at races inspired Kathy to jump from a half-Ironman goal to committing to a full Ironman, just to hear her name called at the finish line. Overcoming Skill Barriers: Learning to ride a clip-in bike and swim in open water from scratch, including handling race-day setbacks like losing wetsuit privileges in the Hudson River. The Power of Anchors & Visualization: Using mental pre-framing, songs (like Queen's Bicycle), and arm tattoos to push past intense physical discomfort. Navigating Medical Validation & Chronic Pain: Kathy's journey through a year and a half of debilitating nerve pain, the mental toll of second-guessing herself, and the relief of finding the right surgeon. Compartmentalization in Crisis: Managing a cancer diagnosis just two days before her son's wedding while remaining fully present for her family. Please join us for this inspiring episode and story!

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  Episode resource links:  Zhou H et al.  Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355.  eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884  Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041   Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257  Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698.  Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930.  Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541.  Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.:  American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022.  Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485.  Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234.  Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455  Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666  Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301.  Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015  Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024  Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575  Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1  Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

On this episode of SurgOnc Today, Dr. Frederick Dirbas leads a conversation with Drs. Akiko Chiba and Anna Beck, discussing the evolving landscape of endocrine therapy for hormone receptor positive breast cancer in both the adjuvant and neoadjuvant settings.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into groundbreaking scientific advancements, crucial regulatory updates, and strategic industry movements that are shaping the future of patient care and drug development. AstraZeneca, in collaboration with Daiichi Sankyo, has achieved a significant milestone with their antibody-drug conjugate, Enhertu, combined with Roche's Perjeta. This combination therapy has recently secured European Union approval for first-line treatment of HER2-positive metastatic breast cancer. The approval highlights the transformative potential of antibody-drug conjugates in treating aggressive breast cancer subtypes. Enhertu targets HER2-positive tumors by delivering cytotoxic agents directly to the cancer cells, thereby minimizing off-target effects and enhancing efficacy. Such innovations underscore the industry's commitment to improving therapeutic outcomes for patients facing complex medical challenges. In another notable development, Novartis has entered into a substantial $3.2 billion licensing agreement with Alteogen, focusing on ALT-B4 hyaluronidase technology. This collaboration emphasizes the growing interest in subcutaneous drug formulations that offer improved patient compliance and convenience compared to traditional intravenous routes. Hyaluronidase helps disperse and absorb subcutaneously injected drugs more efficiently by degrading hyaluronic acid in tissues, thereby enhancing bioavailability and reducing injection volumes. Shifting gears to clinical trial advancements, Hutchmed's combination therapy featuring Tagrisso (osimertinib) and Orpathys (savolitinib) has achieved a Phase 3 success in first-line treatment for MET-overexpressing non-small cell lung cancer. This marks an important stride towards personalized medicine approaches that target specific genetic mutations driving tumor growth. The success of this combination therapy points to a future where targeted treatments become more prevalent in addressing complex oncogenic drivers. In the realm of strategic partnerships, Novacyt and Illumina have embarked on a five-year collaboration focusing on diagnostics and DNA sequencing technologies. This partnership aims to leverage Illumina's genomic sequencing expertise to advance precision medicine efforts in diagnostics, further highlighting the importance of collaborations in overcoming technological hurdles. Meanwhile, in gene therapy developments, NewBiologix and Synastra Biotechnology have joined forces to develop stable recombinant adeno-associated viral cell lines for Duchenne muscular dystrophy therapies. Their partnership aims to address manufacturing challenges associated with gene therapies for rare diseases, potentially accelerating treatment availability for patients in need. Despite these promising advancements, the industry is not without its challenges. Cellares recently announced significant job cuts following the loss of a contract with Bristol Myers Squibb for cell therapy production. Additionally, regulatory scrutiny remains high as evidenced by the UK Medicines and Healthcare products Regulatory Agency's suspension of Amgen's Tavneos amid concerns over trial data integrity. Such developments underscore the critical importance of maintaining rigorous data standards in drug development. Turning our attention to regulatory dynamics, the Trump administration has introduced a new drug pricing model under Medicare, providing weight loss medications at reduced prices for eligible seniors. This initiative involves major players like Eli Lilly and Novo Nordisk and aims to enhance access to obesity treatments for seniors—a move that could signify a shift towards preventive healthcare. On the clinical front, Alnylam Pharmaceuticals' next-generation gene-silencing technology shows promise for treating transthyretin amyloidosis with cardiomyopathy (ATTR-CM). Despite setbacks faced by AstraZeneca and Ionis Pharmaceuticals in similar trials, Alnylam's approach holds potential when used alongside standard treatments. The pharmaceutical sector also sees evolving market dynamics with reverse mergers rising sharply by 1,600% in Q3. This trend rivals traditional IPOs as companies seek alternative routes to liquidity amid fluctuating investor sentiments. Such strategic adaptations reflect the industry's resilience amidst economic uncertainties. In conclusion, these developments paint a picture of an industry dynamically adapting to technological advancements, regulatory changes, and market demands. From innovative drug delivery technologies to strategic partnerships and robust regulatory frameworks, the sector remains committed to advancing precision medicine and improving patient care globally. As these trends continue to unfold, they promise significant implications for drug development processes and therapeutic paradigms across various disease landscapes.Support the show

Dr. Elizabeth or Liz Hall is Professor of Psychology at Rosemead School of Psychology, Biola University in La Mirada, California, where she researches and teaches at the intersection of suffering, meaning-making, and Christian spirituality. For over 30 years she has been exploring how faith and psychology can work together to help people flourish—especially amid suffering. She also coauthored Relational Spirituality with her husband, Todd, and has published over 150 academic works.In my time with Dr. Hall, we discuss her most recent book, entitled When the Journey Hurts: Finding Meaning in Suffering for Heart, Mind, and Soul. In her book, and in our time together, she shares about her own personal experience with breast cancer and her learnings from her extensive research on suffering. Specifically, she discusses how suffering can lead to flourishing, how she holds on to God's goodness and beauty amidst life's difficulties, and how suffering can open us up to God's presence.  Truth be told, I was surprised to come away from this conversation on suffering feeling inspired and hopeful. I deeply hope it does the same for you.Buy Melissa L. Johnson's book, Soul-Deep Beauty: Fighting for Our True Worth in a World Demanding Flawless, here. Learn more about Impossible Beauty and join the community here.

After a breast cancer diagnosis, nutrition advice can come from everywhere. Friends, family, social media, supplements and so-called "anti-cancer" diets can leave you wondering what's actually backed by science and what isn't. In this episode of the Pink Ribbon Roller Coaster, Jennifer sits down with Jenny Witherspoon, MS, RD, CSO, LD, Director of Clinical Nutrition & Integrative Services at Stephenson Cancer Center, to bring some clarity to the conversation. Jenny shares practical guidance for nourishing your body during and after cancer treatment, including the importance of hydration, protein and maintaining muscle and strength. She also talks supplements, balanced eating and some of the common nutrition myths that can create unnecessary fear and confusion. Join us for this refreshingly practical conversation about giving your body what it needs, understanding the "why" behind nutrition recommendations and making informed choices throughout the cancer journey.

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  Episode resource links:  Zhou H et al.  Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355.  eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884  Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041   Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257  Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698.  Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930.  Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541.  Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.:  American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022.  Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485.  Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234.  Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455  Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666  Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301.  Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015  Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024  Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575  Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1  Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Metastatic breast cancer cannot be cured but it can be treated. Treatment focuses on disease management while maintaining the best possible quality of life. The unfortunate reality is that a treatment will only work for so long, then another one is needed. Joining us today are two women living with metastatic breast cancer who are sharing their experiences, living one treatment to the next. They are tireless advocates for research and the breakthroughs that will ensure their next treatment is available, when they need it. They're sharing how they live life to the fullest and manage their day-to-day care. Key Takeaways It's important to find hope while living treatment to treatment Recognize the physical and emotional toll of treatment, even when you look well Advocate for research, clinical trials, and discoveries that lead to better treatments Live in the present, prioritize quality of life, and give yourself grace Chapters 00:00 — Living with metastatic breast cancer 03:25 — The reality of treatment after treatment 07:45 — The emotional weight of uncertainty 13:23 — Why metastatic breast cancer research matters 26:34 — Living in the present and finding hope Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

A Boise State scientist is uncovering how an inflammatory protein may be helping cancer spread to the lymph nodes, lungs and bones and whether blocking it could help stop cancer.

SPONSORED BY NURP Nurp is algorithmic trading designed specifically for busy professionals who don't have time to watch markets. Check out start.nurp.com/doctors to learn more. --- What happens when the healthcare system built to treat illness leaves patients feeling unsupported, overwhelmed, and responsible for coordinating their own care? At just 23 years old, Chloe Harrouche was diagnosed with breast cancer. Although she had specialists guiding each part of her treatment, no one was managing the complete picture. After treatment, she encountered another major gap: little meaningful guidance on prevention, nutrition, fertility, or long-term wellness. That experience inspired Chloe to co-found The Lanby, a modern concierge medical practice designed to make primary care more proactive, coordinated, and patient-centered. In this conversation, Chloe joins May and Tim to discuss how her experience as a patient shaped her vision for a different kind of healthcare. They explore the shortcomings of traditional fee-for-service medicine, the value of coordinated care, and why prevention and wellness should be central to primary care—not an afterthought. In This Episode Chloe's breast cancer diagnosis at age 23 Navigating treatment without anyone coordinating the full picture Why traditional medicine often prioritizes treatment over prevention The lack of support patients receive after surviving a serious illness Chloe's difficult fertility journey and path to motherhood Why women frequently place their own health last The problems created by rushed, fragmented medical care How membership-based medicine can better align patients and providers The role of nutrition, wellness, and care coordination in primary care How The Lanby is working to create a more supportive patient experience About Chloe Harrouche Chloe Harrouche is the co-founder and CEO of The Lanby, a modern concierge medical practice in New York City that combines primary care, functional medicine, wellness, and care coordination. Her experience as a young breast cancer survivor gave her firsthand insight into the gaps patients face when navigating complex medical care. Drawing on her background in bioengineering, healthcare strategy, and technology consulting, Chloe helped build The Lanby around a proactive, relationship-based approach to health. Connect with Chloe and The Lanby Learn more about Chloe HarroucheVisit The LanbyConnect with Chloe on LinkedInListen to The Lanby's Get Well, Better podcast Connect with BS Free MD BS Free MD WebsiteInstagram If you enjoyed this episode, follow the podcast and share it with someone ready for a more proactive, patient-centered approach to healthcare. This podcast is for entertainment and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional regarding your individual medical needs. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  Episode resource links:  Zhou H et al.  Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355.  eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884  Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041   Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257  Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698.  Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930.  Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541.  Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.:  American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022.  Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485.  Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234.  Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455  Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666  Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301.  Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015  Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024  Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575  Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1  Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene & Dr. Dennis Holmes discuss the article: "Cryoablation: A Minimally Invasive Alternative for Early-Stage Breast Cancer: 6-Year Outcomes of the FROST Clinical Trial" from the April 2026 issue of the Annals of Surgical Oncology.

Increasing the fiber in your diet may seem unimportant and not very impactful on your breast health, but in today's episode, I'll share what the research really says about that. Adding more fiber to your diet is a safe and practical way to improve your overall health, while potentially decreasing your recurrence risk. Could that be true? Yes! After today's episode you'll understand: Why fiber is so important to add to your dietThe powerful benefits of fiber foodsHow to eat the recommended amount of daily fiber_____________________________________________________Click here to submit a booking request for THE CLARITY SESSIONSClick here to get my brand new FREE guide; The 5 Foods Breast Cancer Survivors Worry About Most (and what the science really says)Follow me on Instagram @hormone.breastcancer.dietitian

Love the podcast? Send us a text!When Vic Clevenger's mother was diagnosed with breast cancer, he and his brother had a thought that many men probably share:At least we're not women. We don't have to worry about breast cancer.Years later, Vic learned firsthand just how wrong that assumption can be.It started with what looked like a stain on his shirt. When Vic realized fluid was coming from his nipple, he initially assumed it was probably a cyst, pimple, or something minor.His fiancée encouraged him to get it checked.Even then, Vic says his concerns were initially dismissed because male breast cancer was considered "too rare." But Vic knew something wasn't right and sought another opinion.A mammogram and biopsy ultimately confirmed breast cancer.In this episode of Breast Cancer Conversations, Vic joins Laura Carfang for an honest—and often surprisingly funny—conversation about male breast cancer, self-advocacy, genetic testing, masculinity, body image, and learning to live fully after a cancer diagnosis.Vic shares his experience undergoing a double mastectomy and radiation, taking ongoing hormone therapy, and later discovering that he carries a BRCA2 mutation. His family's genetic testing also challenged another common assumption: hereditary breast cancer risk doesn't only come from your mother's side of the family.In this episode, we discuss:Yes, men can get breast cancerThe unexpected symptom that led Vic to seek medical careWhy nipple discharge or other breast changes shouldn't be ignoredWhat happened when Vic's concerns were initially dismissedHaving a mammogram and biopsy as a manVic's experience with a double mastectomy and surgical drainsBody image and the emotional impact of mastectomy for menUsing humor to navigate cancer and recoveryBRCA2 mutations and understanding family historyWhy family history on both sides mattersThe importance of genetic counseling and testing when appropriateFear of recurrence and life after treatmentWhy some men may delay going to the doctorHow breast cancer organizations can make male patients feel more includedWhy self-advocacy and second opinions can matterVic's perspective on getting a "second lease on life"Vic also shares an important challenge for healthcare providers and cancer organizations: don't make men hunt for information about male breast cancer.While male breast cancer is uncommon, the people diagnosed with it deserve information, resources, and support that recognize their experiences.And Vic's message to other men is one worth sharing:If you notice something different in your body, don't ignore it. Get it checked. And if you don't feel like your concerns are being taken seriously, keep asking questions.Because breast cancer isn't exclusively a women's disease.Support the showListener FeedbackIf this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.Messages are completely anonymous.If you would like us to follow up directly, please include your email address in your message so we can respond.Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Become a Breast Cancer Conversations+ Member! Sign Up Now. Enjoying our content? Please consider supporting our work. 

Show notes and links: https://www.chrisbeatcancer.com/how-sasha-petrovic-healed-triple-positive-breast-cancer-holistically

How do you know whether it is time to push forward, hold steady, or give yourself permission to stop? Most of us never ask. We just keep pressing, adding the next hard thing, without checking whether we have the reserves to carry it. In this episode, I borrow a simple idea from metabolic wellness and show you how it maps onto the way we live, and I get honest about what it looked like to let myself pause without guilt. Sometimes the most powerful thing you can do is make space.   Resources Mentioned: Join the Living Well After Breast Cancer Community: https://www.thebreastcancerrecoverycoach.com/offers/iEbrAWpd/checkout Download for iPhone:  https://apps.apple.com/us/app/kajabi/id1485646310 Download for Android:  https://play.google.com/store/apps/details?id=kajabi.kajabiapp&hl=en_US   Let's Connect! If this episode helped you breathe a little easier, please share it with a friend or leave a review. Every share helps spread this message of hope, healing, and whole-person wellness.

Thanks to our Partners: NAPA TRACS, Today's Class, KUKUI, and Pit Crew Loyalty Watch Full Video Episode What if your auto repair shop could help advance breast cancer research while growing your business? Co-founders Leigh Anne Best and Laura Frank, alongside Dr. Justin Johnson from the Cleveland Clinic, share the story behind one of the automotive industry's most impactful grassroots fundraisers. Since 2011, participating shops have partnered with parts vendors to provide free brake pads during October, helping customers save on repairs while shops donate 10% of the total service cost to breast cancer vaccine research at Cleveland Clinic. With $2.4 million raised and a $3 million milestone in sight, the campaign is helping fund continued research into the alpha-lactalbumin breast cancer vaccine for triple-negative breast cancer while giving independent repair shops an opportunity to strengthen their communities and grow their business. What You'll Learn How the Brakes for Breasts win-win fundraising model works.How participating shops can partner with parts vendors and customers.Why 100% of donations go directly to the research laboratory.How grassroots funding helped keep the Cleveland Clinic research lab open after Dr. Vincent Tuohy's passing.What Phase 1 vaccine research revealed and what Phase 2 will require.How participating shops can generate community awareness and increased car count.How your shop can participate and access promotional resources. Brakes for Breasts demonstrates what can happen when the automotive industry comes together around a cause. Shops can serve their customers, strengthen their communities, grow their businesses, and help fund research that could change lives. Every shop, every customer, and every dollar can make a difference. https://www.brakesforbreasts.com/ The First Breast Cancer Vaccine Trial Recipient Jennifer Davis: https://remarkableresults.biz/remarkable-results-radio-podcast/cc111/ NAPA TRACS will move your shop into the SMS fast lane with onsite training, six days a week of support, and local representation. http://napatracs.com/ Optimize training with Today's Class: In just 5 minutes daily, boost knowledge retention and improve team performance. https://www.todaysclass.com/ Stop juggling multiple marketing tools. KUKUI's integrated platform delivers 4x better website conversions, automated follow-up, and real-time ROI tracking. https://www.kukui.com/ You're probably tired of chasing new customers who never return. Pit Crew Loyalty ends the one-and-done cycle, turning first visits into lasting, reliable revenue at https://www.pitcrewloyalty.com/ Connect with the Podcast: Download and Listen on Our Mobile App: https://automotiverepairpodcastnetwork.com/app/Visit the Website:https://remarkableresults.biz/Subscribe on YouTube:https://www.youtube.com/carmcapriottoFollow on Facebook:https://www.facebook.com/RemarkableResultsRadioPodcast/Follow on LinkedIn:https://www.linkedin.com/in/carmcapriotto/Follow on Instagram:https://www.instagram.com/remarkableresultsradiopodcast/Join Our Virtual Toastmasters Club:https://remarkableresults.biz/toastmastersJoin Our Private Facebook Community:https://www.facebook.com/groups/1734687266778976Join our Insider List:https://remarkableresults.biz/insiderAll books mentioned on our podcasts:https://remarkableresults.biz/booksOur Classroom page for personal or team learning:https://remarkableresults.biz/classroomBuy Me a Coffee:https://www.buymeacoffee.com/carmSpecial episode collections:https://remarkableresults.biz/collections The Automotive Repair Podcast Network:

Dr. Jenn Simmons and Dr. Bradley Campbell unpack why autoimmune disease is rising, why so many patients are dismissed for years, and why symptom suppression alone often makes things worse. This conversation focuses on root causes, especially gut dysfunction, stress, and immune triggers, and explains why individualized care matters more than one-size-fits-all treatment.Dr. Campbell shares how his work evolved from injury care into complex autoimmune cases, while Dr. Simmons brings the perspective of conventional medicine, cancer care, and the limits of training that does not teach health optimization.Key topicsIn this episode, Dr. Simmons opens with a blunt critique of how poorly autoimmune disease is understood in conventional medicine, especially when labs are “normal” but patients are clearly unwell.Dr. Campbell explains how autoimmune cases found him through patients with chronic, rare, and complex conditions that mainstream care could not resolve.We discuss the gap between medical training and real-world health care, including the difference between knowing how to prescribe and knowing how to create health.Dr. Simmons and Dr. Campbell agree that the system rewards sickness management, not healing, and that insurance incentives often push short visits, prescriptions, and procedures over root-cause work.In this episode: low iron is treated as a major red flag for digestive dysfunction, malabsorption, celiac disease, low enzymes, or bile flow problems, not just a number to supplement away.We discuss why proton pump inhibitors can create long-term digestive problems by reducing stomach acid, impairing digestion, and contributing to dysbiosis and infection risk.Dr. Campbell outlines his autoimmune screening approach, including ANA, ENA panels, thyroid antibodies, hormone testing, food sensitivity workups, and broader root-cause diagnostics.The autoimmune triad comes up in detail: genetics, gut dysfunction, and a trigger such as physical trauma, infection, medication, food reaction, or emotional stress.We discuss parasites as a controversial but real variable in some autoimmune cases, especially in the context of protozoa, gut imbalance, and chronic thyroid issues.Dr. Simmons and Dr. Campbell both push back on rigid diets and medical absolutism, arguing for individualized decisions around grains, dairy, nightshades, and autoimmune protocols.The conversation closes with a strong emphasis on stress, nervous system overload, childhood trauma, and the need for quiet, reflection, and community without constant screen input.Timestamps00:00 - Why autoimmune disease is exploding and often missed for years 03:15 - How Dr. Campbell's path shifted from music and injuries to autoimmune care 06:23 - Why medical training is a foundation, not a complete education in health 08:49 - Doctors as well-intentioned players inside a broken system 11:10 - Why screening versus symptom-based testing must be treated differently 13:20 - Autoimmune disease is highly individualized, even when diagnoses look similar 14:23 - Why celiac disease is often found only after a breast cancer diagnosis 16:36 - Why 30 patients a day leaves no room for root-cause medicine 19:34 - Insurance incentives reward sickness instead of health 23:55 - Years of delayed diagnosis and the cost of being told labs are “normal” 26:52 - Low iron as a clue to digestion, not just iron deficiency 28:19 - Why stomach acid matters for digestion, immune protection, and bile signaling 31:03 - How Heidelberg testing evaluates stomach acidity in real time 33:39 - What Dr. Campbell looks for that many providers miss in autoimmune cases 36:09 - The autoimmune triad: genetics, gut dysfunction, and a trigger 37:34 - Structural, biochemical, and emotional triggers that can set off autoimmunity 40:28 - Parasites, terrain, and why over-treatment is not always the answer 43:44 - Vaccine-era inflammation, informed consent, and autoimmune flare concerns 48:59 - A better model for autoimmune disease: the immune system is trying to do something 51:02 - The autoimmune protocol diet and when a less restrictive approach is better 53:31 - Nightshades, liver function, and why food rules should not be universal 56:13 - Why grains and dairy are not automatically bad for everyone, but can be poor fits in active disease 61:34 - Blood sugar, energy, mood, and why kids often need more real food 63:41 - Why processed protein bars and powders are often worse than whole foods 65:49 - Food transitions at home: why change is hard even when the benefits are obvious 67:46 - Root-cause thinking applies to MS, breast cancer, dementia, osteoporosis, and diabetes 70:03 - Dr. Campbell's membership community, weekly teaching, and lab support 71:30 - GLP-1 drugs: useful tools for some, but not a shortcut for lifestyle change 74:42 - Stress, trauma, quiet time, and why emotional load drives chronic disease 76:55 - Why unresolved trauma and a lack of safety can affect healing for yearsTo talk to a member of Dr. Jenn's team and learn more about working with Dr. Jenn visit: https://calendly.com/stephanie-1031/clarity-callTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideConnect with Dr. Jenn:Website:  https://www.perfeqtionimaging.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons

Le Tour de Femme is more than a women's bike ride.In this episode of the Find Your Edge Podcast, Coach Chris Newport talks with Catherine Davis and Nesha Daubenspeck about the story and mission behind Le Tour de Femme—a cycling event created to both empower women to explore cycling and support women going through cancer.Catherine's connection to the event is especially powerful: she discovered Le Tour de Femme in a breast cancer support group and completed her first ride in 2009 while undergoing chemotherapy.We talk about:• How Le Tour de Femme began • Catherine's journey from rider to event leadership • Why women-centered cycling communities matter • Using cycling to build confidence and connection • Supporting women navigating cancer • The event's new chapter with One of Us • Why you don't have to be an experienced cyclist to find your place in the sportWhether you've been riding for years or are wondering if cycling could be for you, this conversation is a reminder of just how powerful movement and community can be.Learn more here: https://www.theenduranceedge.com/le-tour-de-femme-womens-cycling-cancer-community/ Learn more about our Fall Women's Endurance Athlete Retreat here: https://www.theenduranceedge.com/triathlon-training-camp/#womens-retreatRegister to ride here: https://www.letourdefemme.orgWant a supportive endurance community of your own? Learn about The Endurance Edge Group Training & Club: https://www.theenduranceedge.com/group-triathlon-training-club/Ready to make a season's worth of progress in just one day? Join us for an Ultimate Training Day and receive personalized coaching, hands-on swim, bike, and run instruction, and actionable feedback you can use immediately. Plus, connect with an incredible community of athletes and coaches. Space is intentionally limited to ensure personalized attention, so register early at TheEnduranceEdge.com/camps  Support the show

A top pathologist looked at Elina Fuhrman's cancer diagnosis and gave her four words that had nothing to do with a treatment plan: change your life.In this episode of Integrative Cancer Solutions, Dr. K sits down with Elina Fuhrman, a former CNN journalist and founder of Soupalina, to talk about the breast cancer diagnosis that upended a life she thought was already good. Elina found a lump in the shower at 40, was told in the middle of her own biopsy that it didn't look good, and within days was facing pressure to schedule surgery the next morning. Looking for a second opinion, she found something she wasn't expecting: a pathologist who told her the numbers on her chart were only half the story.This conversation covers why Elina chose a lumpectomy, stopped radiation partway through, and refused chemotherapy altogether, and the years of digging that followed to find what she calls her own tipping point: toxic burden, unresolved trauma, and years of running on three hours of sleep a night. She explains how that search became Soupalina, first a set of healing soups she made for her own recovery, and now a service where she spends days inside a client's home turning it into what she calls a healing sanctuary. If you or someone you love is trying to figure out what actually needs to change after a cancer diagnosis, this episode is a place to start.Key Takeaways:0:00 Introduction 3:44 Escaping the Soviet Union with only $61 and no plan 11:00 Finding a lump in the shower and knowing immediately 13:00 Told "it's not looking good at all" during her own biopsy 19:00 A top pathologist's real answer: change your life 21:45 The hidden causes behind her cancer: toxic burden, trauma and three hours of sleep a night 25:51 Turning a client's home into a healing sanctuary 30:16 Lumpectomy, stopping radiation halfway through and refusing chemo Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902Resources:Soupelina - https://soupelina.com Medical Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or replace professional medical advice. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions.

After four decades in the modeling industry, Christine Handy's life changed when she was diagnosed with breast cancer at 41.Her journey forced her to look beyond external beauty and discover a deeper sense of self-worth, faith, courage, and purpose. In this episode, Christine shares how she transformed a life-altering experience into a mission to help others — from writing Walk Beside Me to returning to the runway to champion women affected by breast cancer.We talk about redefining beauty, finding strength through adversity, the power of showing up for others, and how storytelling can become a powerful form of healing.In this episode, you'll discover:The danger of relying on external validation to define your worthCourage during long trials of difficulty or illnessBeing a vine not a victimThe role of faith, friendship, and self-love in healingEpisode Resources:⁠⁠⁠⁠Christine Website: https://christinehandy.com/Christine Instagram: https://www.instagram.com/christinehandy1/